This study aimed to investigate the hypoglycemic effects of different concentrations of black tea (BT) extracts and their underlying mechanisms in type 2 diabetic (T2DM) mice. Results indicated that BT extracts significantly mitigated weight loss, improved glucose and insulin tolerance, and modulated cytokine levels related to glucose and lipid metabolism in T2DM mice. Moreover, BT extracts ameliorated liver and pancreas damage resulting from high-sugar/high-fat diets and insulin resistance. Among the tested concentrations, low-concentration BT (BT-L) extract exhibited the most potent hypoglycemic ability. Furthermore, BT-L restored pancreatic function in hyperglycemic mice via activating the glucagon-like peptide-1 receptor–protein kinase A–pancreatic and duodenal homeobox-1–glucokinase cascade pathway. In terms of intestinal homeostasis, all BT-treated groups adjusted the gut microbiota structure by regulating the distribution and diversity of gut microbiota in T2DM mice. Among them, BT-L intervention specifically and significantly increased the levels of probiotic Bifidobacterium in the intestine of T2DM mice. Furthermore, BT-L intervention effectively promoted the synthesis of streptomycin by gut microbiota, thereby exerting anti-inflammatory effect. Comprehensively, the hypoglycemic effect of BT cannot show an absolute concentration-dependent relationship. Our findings highlight the potential of BT as an effective blood glucose regulator and provide valuable insights for BT-based functional food development.
Get full access to this article
View all access options for this article.
References
1.
SunH, SaeediP, KarurangaS, et al.IDF diabetes atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Research and Clinical Practice, 2022; 183:109119; doi: 10.1016/j.diabres.2021.109119
2.
WangQ, WuX, ShiF, et al.Comparison of antidiabetic effects of saponins and polysaccharides from Momordica charantia L. in STZ-induced type 2 diabetic mice. Biomed Pharmacother, 2019; 109:744–750; doi: 10.1016/j.biopha.2018.09.098
3.
ForouhiNG, MisraA, MohanV, et al.Dietary and nutritional approaches for prevention and management of type 2 diabetes. BMJ, 2018; 361:k2234; doi: 10.1136/bmj.k2234
4.
ValdesAM, WalterJ, SegalE, et al.Role of the gut microbiota in nutrition and health. BMJ, 2018; 361:k2179; doi: 10.1136/bmj.k2179
5.
ChenL, LiuB, RenL, et al.High-fiber diet ameliorates gut microbiota, serum metabolism and emotional mood in type 2 diabetes patients. Front Cell Infect Microbiol, 2023; 13:1069954; doi: 10.3389/fcimb.2023.1069954
6.
GuanR, MaN, LiuG, et al.Ethanol extract of propolis regulates type 2 diabetes in mice via metabolism and gut microbiota. J Ethnopharmacol, 2023; 310:116385; doi: 10.1016/j.jep.2023.116385
7.
WuJ, YangK, FanH, et al.Targeting the gut microbiota and its metabolites for type 2 diabetes mellitus. Front Endocrinol (Lausanne), 2023; 14:1114424; doi: 10.3389/fendo.2023.1114424
8.
NeuenschwanderM, BallonA, WeberKS, et al.Role of diet in type 2 diabetes incidence: Umbrella review of meta-analyses of prospective observational studies. BMJ, 2019; 366:l2368; doi: 10.1136/bmj.l2368
9.
YangCS, WangH, SheridanZP. Studies on prevention of obesity, metabolic syndrome, diabetes, cardiovascular diseases and cancer by tea. J Food Drug Anal, 2018; 26(1):1–13; doi: 10.1016/j.jfda.2017.10.010
10.
ChenT, LiuAB, SunS, et al.Green tea polyphenols modify the gut microbiome in db/db mice as Co-Abundance groups correlating with the blood glucose lowering effect. Mol Nutr Food Res, 2019; 63(8):e1801064; doi: 10.1002/mnfr.201801064
11.
ZhuJ, WuM, ZhouH, et al.Liubao brick tea activates the PI3K-Akt signaling pathway to lower blood glucose, metabolic disorders and insulin resistance via altering the intestinal flora. Food Res Int, 2021; 148:110594; doi: 10.1016/j.foodres.2021.110594
12.
SinghBN, RawatAK, BhagatRM, et al.Black tea: Phytochemicals, cancer chemoprevention, and clinical studies. Crit Rev Food Sci Nutr, 2017; 57(7):1394–1410; doi: 10.1080/10408398.2014.994700
13.
HuangJ, XieZ, WangY, et al.Recent advances of anti-hyperglycemia and anti-diabetes actions of tea in animal studies %J. Current Opinion in Food Science. Current Opinion in Food Science, 2015; 2:78–83; doi: 10.1016/j.cofs.2015.02.001
14.
ZhouH, LiF, WuM, et al.Regulation of glucolipid metabolism and gut microbiota by green and black teas in hyperglycemic mice. Food Funct, 2023; 14(9):4327–4338; doi: 10.1039/d3fo00355h
15.
SmithNK, HackettTA, GalliA, et al.GLP-1: Molecular mechanisms and outcomes of a complex signaling system. Neurochem Int, 2019; 128:94–105; doi: 10.1016/j.neuint.2019.04.010
16.
GuoH, WuH, LiZ. The pathogenesis of diabetes. Int J Mol Sci, 2023; 24(8):6978; doi: 10.3390/ijms24086978
17.
MaloneJI, HansenBC. Does obesity cause type 2 diabetes mellitus (T2DM)? Or is it the opposite? Pediatr Diabetes, 2019; 20(1):5–9; doi: 10.1111/pedi.12787
18.
Galicia-GarciaU, Benito-VicenteA, JebariS, et al.Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci, 2020; 21(17):6275; doi: 10.3390/ijms21176275
19.
LeeCJ, SearsCL, MaruthurN. Gut microbiome and its role in obesity and insulin resistance. Annals of the New York Academy of Sciences, 2020; 1461(1):37–52; doi: 10.1111/nyas.14107
20.
OdegaardAO, PereiraMA, KohWP, et al.Coffee, tea, and incident type 2 diabetes: The Singapore Chinese Health Study. Am J Clin Nutr, 2008; 88(4):979–985; doi: 10.1093/ajcn/88.4.979
21.
RennoWM, AbdeenS, AlkhalafM, et al.Effect of green tea on kidney tubules of diabetic rats. Br J Nutr, 2008; 100(3):652–659; doi: 10.1017/s0007114508911533
22.
ShangL, LiF, ZhuJ, et al.Selenium-enriched and ordinary black teas regulate the metabolism of glucose and lipid and intestinal flora of hyperglycemic mice. Plant Foods Hum Nutr, 2023; 78(1):61–67; doi: 10.1007/s11130-022-01022-w
23.
WuG, SunX, ChengH, et al.Large yellow tea extract ameliorates metabolic syndrome by suppressing lipogenesis through SIRT6/SREBP1 pathway and modulating microbiota in leptin receptor knockout rats. Foods, 2022; 11(11):1638; doi: 10.3390/foods11111638
24.
MiaoL, St ClairDK. Regulation of superoxide dismutase genes: Implications in disease. Free Radic Biol Med, 2009; 47(4):344–356; doi: 10.1016/j.freeradbiomed.2009.05.018
25.
NwoseEU, JelinekHF, RichardsRS, et al.Atherothrombosis and oxidative stress: The connection and correlation in diabetes. Redox Rep, 2009; 14(2):55–60; doi: 10.1179/135100009x392458
26.
GupteM, UmbarkarP, SinghAP, et al.Deletion of cardiomyocyte glycogen synthase Kinase-3 Beta (GSK-3β) improves systemic glucose tolerance with maintained heart function in established obesity. Cells, 2020; 9(5):1120; doi: 10.3390/cells9051120
27.
NiD, AiZ, Munoz-SandovalD, et al.Inhibition of the facilitative sugar transporters (GLUTs) by tea extracts and catechins. Faseb J, 2020; 34(8):9995–10010; doi: 10.1096/fj.202000057RR
LeeYS, JunHS. Anti-diabetic actions of glucagon-like peptide-1 on pancreatic beta-cells. Metabolism, 2014; 63(1):9–19; doi: 10.1016/j.metabol.2013.09.010
30.
ChoYM, FujitaY, KiefferTJ. Glucagon-like peptide-1: Glucose homeostasis and beyond. Annu Rev Physiol, 2014; 76:535–559; doi: 10.1146/annurev-physiol-021113-170315
31.
AshizawaS, BrunicardiFC, WangXP. PDX-1 and the pancreas. Pancreas, 2004; 28(2):109–120; doi: 10.1097/00006676-200403000-00001
32.
LiuJ, LangG, ShiJ. Epigenetic regulation of PDX-1 in Type 2 diabetes mellitus. Diabetes Metab Syndr Obes, 2021; 14:431–442; doi: 10.2147/dmso.S291932
33.
OsbakKK, ColcloughK, Saint-MartinC, et al.Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia. Hum Mutat, 2009; 30(11):1512–1526; doi: 10.1002/humu.21110
34.
LarsenN, VogensenFK, van den BergFW, et al.Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One, 2010; 5(2):e9085; doi: 10.1371/journal.pone.0009085
35.
ZhangT, LiQ, ChengL, et al.Akkermansia muciniphila is a promising probiotic. Microb Biotechnol, 2019; 12(6):1109–1125; doi: 10.1111/1751-7915.13410
36.
GomesC, MoreiraRG, Castell-PerezE. Radiosensitization of Salmonella spp. and Listeria spp. in ready-to-eat baby spinach leaves. Journal of Food Science, 2011; 76(1):E141–E8; doi: 10.1111/j.1750-3841.2010.01904.x
37.
BuiTPN, Mannerås-HolmL, PuschmannR, et al.Conversion of dietary inositol into propionate and acetate by commensal Anaerostipes associates with host health. Nat Commun, 2021; 12(1):4798; doi: 10.1038/s41467-021-25081-w
38.
CuiY, ZhangL, WangX, et al.Roles of intestinal Parabacteroides in human health and diseases. FEMS Microbiol Lett, 2022; 369(1); doi: 10.1093/femsle/fnac072
39.
SattiM, ModestoM, EndoA, et al.Host-Diet effect on the metabolism of Bifidobacterium. Genes, 2021; 12(4):609; doi: 10.3390/genes12040609
40.
LinL, XuK, ShenD, et al.Antifungal weapons of Lysobacter, a mighty biocontrol agent. Environ Microbiol, 2021; 23(10):5704–5715; doi: 10.1111/1462-2920.15674
41.
PalD, NaskarM, BeraA, et al.Chemical synthesis of the pentasaccharide repeating unit of the O-specific polysaccharide from Ruminococcus gnavus. Carbohydr Res, 2021; 507:108384; doi: 10.1016/j.carres.2021.108384
42.
PompilioA, Di BonaventuraG, GherardiG. An Overview on Streptococcus bovis/Streptococcus equinus complex isolates: Identification to the Species/Subspecies level and antibiotic resistance. IJMS, 2019; 20(3):480; doi: 10.3390/ijms20030480
43.
HerpS, BrugirouxS, GarzettiD, et al.Mucispirillum schaedleri Antagonizes Salmonella virulence to protect mice against colitis. Cell Host Microbe, 2019; 25(5):681–694.e8; doi: 10.1016/j.chom.2019.03.004
44.
Sanchez RamosL, RodloffAC. Identification of Clostridium species using the VITEK(®) MS. Anaerobe, 2018; 54:217–223; doi: 10.1016/j.anaerobe.2018.01.007
45.
LiYX, LuYP, TangD, et al.Anthocyanin improves kidney function in diabetic kidney disease by regulating amino acid metabolism. J Transl Med, 2022; 20(1):510; doi: 10.1186/s12967-022-03717-9
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
